Crossmark Global Holdings Inc. Sells 37,402 Shares of Bath & Body Works, Inc. $BBWI

Crossmark Global Holdings Inc. lowered its position in Bath & Body Works, Inc. (NYSE:BBWIFree Report) by 68.7% in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 17,073 shares of the company’s stock after selling 37,402 shares during the quarter. Crossmark Global Holdings Inc.’s holdings in Bath & Body Works were worth $440,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the company. First Horizon Corp bought a new position in Bath & Body Works during the third quarter worth about $29,000. Geneos Wealth Management Inc. increased its stake in shares of Bath & Body Works by 217.7% in the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after purchasing an additional 801 shares in the last quarter. Parkside Financial Bank & Trust increased its stake in shares of Bath & Body Works by 24.6% in the second quarter. Parkside Financial Bank & Trust now owns 1,842 shares of the company’s stock worth $55,000 after purchasing an additional 364 shares in the last quarter. Carolina Wealth Advisors LLC bought a new stake in shares of Bath & Body Works in the third quarter valued at approximately $54,000. Finally, Westfuller Advisors LLC purchased a new stake in shares of Bath & Body Works during the 3rd quarter valued at approximately $56,000. 95.14% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms recently commented on BBWI. JPMorgan Chase & Co. cut their price objective on shares of Bath & Body Works from $26.00 to $15.00 and set a “neutral” rating for the company in a report on Thursday, November 20th. Barclays boosted their target price on shares of Bath & Body Works from $20.00 to $21.00 and gave the company an “equal weight” rating in a report on Monday, March 2nd. Raymond James Financial reaffirmed a “market perform” rating on shares of Bath & Body Works in a report on Wednesday, November 12th. Jefferies Financial Group started coverage on Bath & Body Works in a research report on Wednesday, January 14th. They issued a “hold” rating and a $24.00 price target for the company. Finally, Telsey Advisory Group boosted their price objective on Bath & Body Works from $23.00 to $25.00 and gave the company a “market perform” rating in a research note on Thursday, March 5th. Three analysts have rated the stock with a Buy rating and fourteen have issued a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $24.00.

Check Out Our Latest Stock Analysis on Bath & Body Works

Bath & Body Works Trading Down 1.9%

Shares of NYSE:BBWI opened at $20.06 on Thursday. The company has a 50 day moving average of $22.42 and a 200 day moving average of $23.27. The stock has a market cap of $4.11 billion, a P/E ratio of 6.37, a P/E/G ratio of 2.04 and a beta of 1.48. Bath & Body Works, Inc. has a 12 month low of $14.27 and a 12 month high of $34.66.

Bath & Body Works (NYSE:BBWIGet Free Report) last posted its earnings results on Wednesday, March 4th. The company reported $2.05 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.77 by $0.28. Bath & Body Works had a net margin of 8.90% and a negative return on equity of 45.60%. The business had revenue of $2.72 billion for the quarter, compared to analysts’ expectations of $2.59 billion. During the same period in the prior year, the company posted $2.09 EPS. The business’s revenue for the quarter was down 2.3% compared to the same quarter last year. Bath & Body Works has set its Q1 2026 guidance at 0.240-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. On average, equities analysts forecast that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 6th. Investors of record on Friday, February 20th were given a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 4.0%. The ex-dividend date was Friday, February 20th. Bath & Body Works’s dividend payout ratio (DPR) is 25.40%.

More Bath & Body Works News

Here are the key news stories impacting Bath & Body Works this week:

  • Neutral Sentiment: Company action: Bath & Body Works announced the redemption of its 2027 senior notes, a move that reduces near‑term debt on the balance sheet but will require cash or refinancing and is therefore broadly neutral to slightly mixed for liquidity and leverage metrics. Article Title
  • Negative Sentiment: New/ongoing litigation risk: Multiple law firms have filed or are soliciting lead‑plaintiff motions in a securities class action against BBWI, alleging investor harm for purchases between June 4, 2024 and Nov 19, 2025; several firms set imminent lead‑plaintiff deadlines (March 13–16). The proliferation of filings and outreach increases legal uncertainty, potential future damages and defense costs — a clear near‑term negative for sentiment. Article Title
  • Negative Sentiment: Multiple firm solicitations & deadlines: Additional firms (Faruqi & Faruqi, Levi & Korsinsky, Rosen, Pomerantz, Bernstein Liebhard, etc.) are actively contacting investors and reminding them of near‑term deadlines to join or seek lead‑plaintiff status — amplifying media coverage and investor anxiety while the case develops. This broad campaign can depress sentiment until the litigation path is clearer. Article Title
  • Negative Sentiment: Operational/earnings risk: A recent Seeking Alpha analysis highlights slowing demand, margin compression (Q4 gross margin down ~100 bps), heavy promotions and a cautious FY‑2026 sales and EPS guide (sales down 2.5–4.5%, EPS $2.40–2.65). That operational outlook raises execution risk and undermines the stock’s near‑term recovery case. Article Title

Bath & Body Works Profile

(Free Report)

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.

Read More

Institutional Ownership by Quarter for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.